Protocolo de acompanhamento farmacoterapêutico para pacientes com insuficiência cardíaca

Abstract

Heart failure (HF) is a chronic syndrome in which the heart is unable to pump blood according to the metabolic demands of tissues. This syndrome has a poor prognosis, and treatment should be started as soon as the diagnosis is made. HF is a disease that arises from other pre-existing ones and, in general, patients with HF are polymedicated and, therefore, require special attention from pharmacists.This disease affects millions of people, and its complications cause serious damage to the quality of life of patients. Knowing this, the pharmacist can help in the treatment of patients with this syndrome and, thus, the creation of this protocol is intended to provide technical information about the disease, as well as details of its epidemiology, risk factors, prevention and treatment. For this, the use of pharmacotherapeutic follow-up models proves to be useful. In the present protocol, the Dáder Method of pharmacotherapeutic follow-up was chosen as it provides a more structured documentation for user care. In this method, we consult with the patient and ask a series of questions, evaluate their medications and laboratory tests, obtain information about their pharmacotherapeutic history, and possible Drug-Related Problems (DRP). At the end, future interventions are agreed with the patient to help with their treatment. Therefore, the pharmacist working in the clinical service should implement this protocol to patients suffering from HF, guided by the proposed forms and encouraging the rational use of medications in order to ensure a safe and effective treatment